Navigation Links
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

ST. DAVID'S, Bermuda, Feb. 13 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its fourth quarter and full year 2007 financial results prior to the market opening on Friday, February 29, 2008.

In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, February 29, 2008 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (877) 548-7906 in the United States and Canada or (719) 325-4899 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 7039154.

The Company

Warner Chilcott is a leading specialty pharmaceutical company focused on developing, manufacturing, and marketing and selling branded prescription products in women's healthcare and dermatology in the United States. WCRX-F


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
2. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
3. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
4. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
5. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
6. NightHawk Radiology Holdings, Inc. Announces Senior Executive Departures
7. VLST Corporation Announces Board and Executive Management Appointments
8. Advance Nanotech Announces Shareholder Proxy Vote Results
9. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
10. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
11. KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent ... viruses is the Epstein Barr Virus (EBV), and one of ... a chronic inflammatory disease that destroys the body’s joints. As ... have high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... BURLINGAME, Calif. , Jan. 14, 2014 As pet owners ... no doubt many of them wrote: "Take better care of my ... and even designer clothes and top-brand carrying cases to take the ... Pet parents might also feel compelled to buy some pricey toys ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... 24, 2011 Pharmaceutical Institute, the leading provider ... biotech industry and a subsidiary of Campbell Alliance, ... Managed Markets Excellence® Account Management Suite of ... effectiveness of managed care account managers by addressing ...
... Haven, Conn.Sequencing DNA base pairs the individual molecules ... researchers working toward personalized medicine. Being able to isolate, ... to tailor diagnostic testing, therapies and treatments based on ... able to isolate individual molecules like DNA base pairs, ...
... Medical, Inc. (OTC Bulletin Board: BIOR ), ... surgical fluid disposal, announced today the Canadian Intellectual Property ... the Company,s Streamway System "for disposing of liquid surgical ... granted to the Company in April of 2011. ...
Cached Biology Technology:Account Management Training Suite Delivers Two Key Performance Dimensions 2Particle trap paves way for personalized medicine 2BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 2BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 3
(Date:7/9/2014)... (July 9, 2014) Emerging fungal pathogens pose ... parasitic group, causing population declines of amphibians, bats, ... University of South Florida published in the prestigious ... acquire behavioral or immunological resistance to a deadly ... , "Acquired resistance is important because it ...
(Date:7/9/2014)... ill children with traumatic injuries have identified an ... to develop a hospital-acquired infection. The study, led ... online in June in the journal Shock ... could lead to the clinical implementation of quick-turnaround ... reverse immune system damage following critical illness or ...
(Date:7/9/2014)... the prevalence of antibiotic-resistant illness, Case Western Reserve ... disabling disease: blocking bacteria,s access to iron in ... siderophore, a small molecule, captures iron from two ... as well as how the body launches a ... appear in a recent edition of The ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3Bacteria hijack plentiful iron supply source to flourish 2
... "dietary fibre". But what is dietary fibre and how do ... Structural Biology Laboratory, in collaboration with groups in Canada, the ... bacteria metabolise the complex dietary carbohydrates found in fruits and ... are about ten times more bacterial cells in the average ...
... alien world of aquatic micro-organisms just got new residents: ... has developed a class of tiny bio-hybrid machines that ... traverse the viscous fluids of biological environments on their ... Gutgsell Professor of mechanical science and engineering, the team ...
... researchers from the University of Nebraska-Lincoln, while using a ... Ice Shelf, unexpectedly discovered a new species of small ... tentacles protruding into frigid water like flowers from a ... it was really an amazing find," said Marymegan Daly, ...
Cached Biology News:York scientists investigate the fiber of our being 2Tiny swimming bio-bots boldly go where no bot has swum before 2New sea anemone species discovered in Antarctica 2New sea anemone species discovered in Antarctica 3New sea anemone species discovered in Antarctica 4